Use of Farnesoid X Receptor Agonists to Treat Nonalcoholic Fatty Liver Disease

By  

Digestive Diseases, Vol. 33, Iss. 3, 2015-05 ,pp. : 426-432

Karger

Access to resources Recommend Favorite

The Farnesoid X Receptor (FXR) as Modulator of Bile Acid Metabolism

By Kuipers Folkert   Claudel Thierry   Sturm Ekkehard   Staels Bart  

Reviews in Endocrine and Metabolic Disorders, Vol. 5, Iss. 4, 2004-12 ,pp. : 319-326

Springer Publishing Company

Access to resources Recommend Favorite

A Nuclear Receptor Ligand Down-Regulates Cytosolic Phospholipase A₂ Expression to Reduce Bile Acid–Induced Cyclooxygenase 2 Activity in Cholangiocytes: Implications of Anticarcinogenic Action of Farnesoid X Receptor Agonists

By Komichi Daisuke   Tazuma Susumu   Nishioka Tomoji   Hyogo Hideyuki   Chayama Kazuaki  

Digestive Diseases and Sciences, Vol. 50, Iss. 3, 2005-03 ,pp. : 514-524

Springer Publishing Company

Access to resources Recommend Favorite

Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease

By  

Digestive Diseases, Vol. 35, Iss. 3, 2017-03 ,pp. : 178-184

Karger

Access to resources Recommend Favorite

Bile acid-induced expression of farnesoid X receptor as the basis for superiority of internal biliary drainage in experimental biliary obstruction

By Wu Lili   Li Wen   Wang Zikai   Yuan Zuohui   Hyder Qurratulain  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 4, 2013-04 ,pp. : 496-503

Informa Healthcare

Access to resources Recommend Favorite